BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2967258)

  • 1. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
    Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
    Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibrinopeptide A and beta-thromboglobulin in major bacterial infections.
    van Hulsteijn H; Fibbe W; Bertina R; Briët E
    Thromb Haemost; 1982 Dec; 48(3):247-9. PubMed ID: 6187081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet and coagulation factors in proliferative diabetic retinopathy.
    Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
    J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PF,VIII/vWF,B-TG and PF4 in diabetic subjects, both type 1 and 2, with and without retinopathy.
    Guastamacchia E; Di Paolo S; Santoro G; Damato A; Nardelli GM; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):499-505. PubMed ID: 2412573
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
    Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
    Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
    Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
    N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy.
    Brooks AM; Hussein S; Chesterman CN; Martin JF; Alford FP; Penington DG
    Thromb Haemost; 1983 Apr; 49(2):123-7. PubMed ID: 6223403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII, von Willebrand factor and platelet adhesiveness in diabetic retinopathy.
    Nozaki H; Hiramatsu K; Arimori S
    Tokai J Exp Clin Med; 1987 Mar; 12(1):7-9. PubMed ID: 3130682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c.
    Coller BS; Frank RN; Milton RC; Gralnick HR
    Ann Intern Med; 1978 Mar; 88(3):311-6. PubMed ID: 305223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
    Davis TM; Moore JC; Turner RC
    Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function in diabetic retinopathy: levels of beta-thromboglobulin and platelet factor 4.
    Fenández-Vigo J; Cordido M; Fernández Sabugal J; Cordido F
    Metab Pediatr Syst Ophthalmol (1985); 1992; 15(1-3):5-8. PubMed ID: 1484500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A.
    Burrows AW
    Horm Metab Res Suppl; 1981; 11():22-5. PubMed ID: 6172350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New methods in coagulation.
    Triplett DA
    Crit Rev Clin Lab Sci; 1981; 15(1):25-84. PubMed ID: 6459909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iloprost reduces procoagulant activity in the extracorporeal circuit.
    Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
    J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease.
    van Oost BA; Veldhuyzen BF; van Houwelingen HC; Timmermans AP; Sixma JJ
    Thromb Haemost; 1982 Dec; 48(3):289-93. PubMed ID: 6187082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function in sickle cell disease during steady state.
    Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
    Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
    Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
    Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet hyperactivity in diabetic retinopathy: etiologic factor or epiphenomenon of microangiopathy?].
    García Pascual L; Simó R; Monasterio J; Soriano B; Ortega AM; Mesa J
    Rev Clin Esp; 1993 May; 192(9):420-3. PubMed ID: 8516505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.